A MODERNA APPROACH The US Food and Drug Administration has released new data that finds the Moderna vaccine is highly protective for adults and prevents severe cases of COVID-19, news that The New York Times explains means the agency is likely to grant emergency authorisation for use on Friday. It is worth noting that America saw deaths from COVID-19 exceed 300,000 this week — a caseload nearly 120,000 higher than the next worst-hit country, Brazil. Moderna announced 94.5% efficacy of its candidate in November in first interim analysis of phase three results and could begin distribution ...